These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34862475)

  • 1. Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota.
    Luo H; Wu H; Wang L; Xiao S; Lu Y; Liu C; Yu X; Zhang X; Wang Z; Tang L
    Commun Biol; 2021 Dec; 4(1):1357. PubMed ID: 34862475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat.
    Meng Y; Liu Y; Fang N; Guo Y
    Pharm Biol; 2019 Dec; 57(1):98-104. PubMed ID: 30757944
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Ding M; Zhou F; Li Y; Liu C; Gu Y; Wu J; Fan G; Li Y; Li X
    Chin Herb Med; 2023 Jul; 15(3):421-429. PubMed ID: 37538867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of Ilexhainanoside D and ilexsaponin A
    Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
    Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
    Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
    Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthraquinones in the aqueous extract of Cassiae semen cause liver injury in rats through lipid metabolism disorder.
    Yang J; Zhu A; Xiao S; Zhang T; Wang L; Wang Q; Han L
    Phytomedicine; 2019 Nov; 64():153059. PubMed ID: 31401496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective Effects of
    Jin W; Cho S; Laxi N; Bao T; Dai L; Yu H; Qi R; Zhang J; Ba G; Fu M
    Molecules; 2022 May; 27(10):. PubMed ID: 35630624
    [No Abstract]   [Full Text] [Related]  

  • 11. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
    Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice.
    Cossiga V; Lembo V; Nigro C; Mirra P; Miele C; D'Argenio V; Leone A; Mazzone G; Veneruso I; Guido M; Beguinot F; Caporaso N; Morisco F
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of
    Kim DS; Zhang T; Park S
    Pharm Biol; 2022 Dec; 60(1):212-224. PubMed ID: 35076339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
    Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
    J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut dysbiosis correction contributes to the hepatoprotective effects of
    Yan X; Wang Y; Ren XY; Liu XY; Ma JM; Song RL; Wang XH; Dong Y; Yu AX; Fan QQ; Wei J; She GM
    Food Funct; 2021 Oct; 12(20):10281-10290. PubMed ID: 34549762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthraquinone and naphthopyrone glycosides from Cassia obtusifolia seeds mediate hepatoprotection via Nrf2-mediated HO-1 activation and MAPK modulation.
    Paudel P; Jung HA; Choi JS
    Arch Pharm Res; 2018 Jun; 41(6):677-689. PubMed ID: 29804278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
    J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.